tiagabine hydrochloride monohydrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
GABITRIL tiagabine (as hydrochloride monohydrate) 10mg tablet bottle
AUST R: 120272
Active ingredients:
tiagabine hydrochloride monohydrate

Dosage form:
Tablet, film coated

Sponsor:
Teva Pharma Australia Pty Ltd

Phone:
1800 288 382

Deletion from market:
30 Jul 2027

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Manufacturing

Management action:
Patients are advised to consult their healthcare professional to discuss alternative treatment options.

GABITRIL tiagabine (as hydrochloride monohydrate) 15mg tablet bottle
AUST R: 120273
Active ingredients:
tiagabine hydrochloride monohydrate

Dosage form:
Tablet, film coated

Sponsor:
Teva Pharma Australia Pty Ltd

Phone:
1800 288 382

Deletion from market:
30 Sep 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Manufacturing

Management action:
Patients are advised to consult their healthcare professional to discuss alternative treatment options.

GABITRIL tiagabine (as hydrochloride monohydrate) 5mg tablet bottle
AUST R: 120271
Active ingredients:
tiagabine hydrochloride monohydrate

Dosage form:
Tablet, film coated

Sponsor:
Teva Pharma Australia Pty Ltd

Phone:
1800 288 382

Deletion from market:
30 Mar 2027

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Manufacturing

Management action:
Patients are advised to consult their healthcare professional to discuss alternative treatment options.